Inventor · disambiguated record
Phillip Berman
Also filed as: BERMAN PHILLIP · BERMAN PHILLIP W
21 granted patents·5 pending applications·471 citations·filing 1985–2018
96Inventor score
Top patents by PatentIndex Score
26 records- 0197US6806055B2HIV envelopolype peptidesGENENTECH INC·Filed 2001·Granted Oct 19, 2004·86 cites·45 claims
- 0295US6331404B1HIV envelope polypeptidesGENENTECH INC·Filed 2000·Granted Dec 18, 2001·44 cites·20 claims
- 0394US6042836AHIV envelope polypeptidesGENENTECH INC·Filed 1998·Granted Mar 28, 2000·84 cites·15 claims
- 0483US6534285B1Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of useGENENTECH INC·Filed 2000·Granted Mar 18, 2003·11 cites·47 claims
- 0580US7041293B1HIV env antibodiesGENENTECH INC·Filed 1998·Granted May 9, 2006·36 cites·17 claims
- 0680US6090392AHIV envelope polypeptides and vaccineGENENTECH INC·Filed 1997·Granted Jul 18, 2000·46 cites·33 claims
- 0774US9731002B2HIV-1 GP 120 V1/V2 antigens and immunological uses thereofUNIV CALIFORNIA·Filed 2013·Granted Aug 15, 2017·2 cites·10 claims
- 0872US6585979B1HIV envelope polypeptides and immunogenic compositionGENENTECH INC·Filed 1999·Granted Jul 1, 2003·24 cites·14 claims
- 0972US5864027AHIV envelope polypeptidesGENENTECH INC·Filed 1994·Granted Jan 26, 1999·19 cites·7 claims
- 1070US5674984AMethod for isolation of unclipped HIV envelope proteinGENENTECH INC·Filed 1994·Granted Oct 7, 1997·23 cites·6 claims
- 1169US10517942B2Polypeptide glycopeptide fragments from the V1/V2 and V3 domains of the HIV-1 envelope protein gp 120UNIV CALIFORNIA·Filed 2016·Granted Dec 31, 2019·1 cites·17 claims
- 1265US2004121317A1HIV envelopolype peptidesGENENTECH INC·Filed 2003·Application pending·0 cites
- 1363US4855224AMolecularly cloned diagnostic product and method of useGENENTECH INC·Filed 1985·Granted Aug 8, 1989·26 cites·34 claims
- 1461US7071322B2HIV envelope polynucleotides and immunogenic compositionGENENTECH INC·Filed 2003·Granted Jul 4, 2006·0 cites·22 claims
- 1561US5853978AMolecularly cloned acquired immunodeficiency syndrome polypeptides and methods of useGENENTECH INC·Filed 1994·Granted Dec 29, 1998·18 cites·14 claims
- 1660US7264817B1Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making itGENENTECH INC·Filed 1995·Granted Sep 4, 2007·20 cites·31 claims
- 1759US10201603B2Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicityUNIV CALIFORNIA·Filed 2017·Granted Feb 12, 2019·0 cites·10 claims
- 1858US2004014172A1Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of useGENENTECH INC·Filed 2003·Application pending·0 cites
- 1957US5851533AVaccine based on membrane bound proteins and process for making themGENENTECH INC·Filed 1994·Granted Dec 22, 1998·15 cites·10 claims
- 2055US2005025779A1HIV-1 envelope glycoproteins having unusual disulfide structureVAXGEN INC·Filed 2004·Application pending·0 cites
- 2154US6693181B2Protein secretionGENENTECH INC·Filed 1999·Granted Feb 17, 2004·7 cites·13 claims
- 2254US2004077013A1Protein secretionGENENTECH INC·Filed 2003·Application pending·0 cites
- 2352US10507239B2V1/V2 fragments of a HIV-1 envelope glycoproteinUNIV CALIFORNIA·Filed 2017·Granted Dec 17, 2019·0 cites·12 claims
- 2450US5849533AMethod for making unclipped HIV envelope proteinGENENTECH INC·Filed 1997·Granted Dec 15, 1998·9 cites·2 claims
- 2545US9782472B2Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicityBERMAN PHILLIP·Filed 2011·Granted Oct 10, 2017·0 cites·12 claims
- 2641US2020231633A1MGAT1-Deficient Cells for Production of Vaccines and Biopharmaceutical ProductsUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Phillip Berman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →